Spectrascience Inc (SCIE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,467 | -3,635 | -4,488 | -2,750 | -9,093 |
| Depreciation Amortization | 791 | 1,424 | 1,592 | 2,239 | 4,574 |
| Accounts receivable | 6 | -7 | 60 | 19 | 27 |
| Accounts payable and accrued liabilities | 378 | 105 | -173 | 139 | 166 |
| Other Working Capital | 1,277 | 924 | 200 | 646 | 352 |
| Other Operating Activity | 503 | -701 | 367 | -1,906 | 1,087 |
| Operating Cash Flow | $-1,513 | $-1,890 | $-2,442 | $-1,613 | $-2,887 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -6 | -4 | -4 |
| Investing Cash Flow | $N/A | $N/A | $-6 | $-4 | $-4 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,455 | 2,020 | 2,606 | 2,167 | 3,306 |
| Common Stock Issued | 0 | 2 | 19 | 9 | N/A |
| Other Financing Activity | -66 | -229 | -190 | -413 | -575 |
| Financing Cash Flow | $1,389 | $1,794 | $2,435 | $1,763 | $2,731 |
| Beginning Cash Position | 128 | 224 | 237 | 90 | 251 |
| End Cash Position | 4 | 128 | 224 | 237 | 90 |
| Net Cash Flow | $-124 | $-96 | $-13 | $146 | $-161 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,513 | -1,890 | -2,442 | -1,613 | -2,887 |
| Capital Expenditure | N/A | N/A | -6 | -4 | -4 |
| Free Cash Flow | -1,513 | -1,890 | -2,448 | -1,617 | -2,892 |